Powerpharma sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2020-01-09
Share capital
5,000.00 PLN
Activity description

Powerpharma is a distribution company registered in the Republic of Cyprus that specializes in pharmaceutical raw materials, specifically active pharmaceutical ingredients (APIs) and excipients. The company focuses on providing high-quality raw materials and ensures prompt delivery to pharmaceutical factories, helping them maintain consistent product quality for their customers.

Registered address
ul. Czeska 9, 20-424 Lublin, Poland
Email

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 788 days for 2020).

  • 2025not filed
  • 202425/06/2025
  • 202324/06/2024
  • 202214/12/2023
  • 202112/12/2023
  • 202012/12/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Offer

  • Active pharmaceutical ingredients
  • Pharmaceutical excipients
  • Pharmaceutical raw material distribution

Websites

Authorized Representatives

Andrzej Krzysztof Wójcik age 53 – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
95$1,283.0995%
Others
5$67.535%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
Novo Nordisk Pharma sp. z o.o.
Imcd Polska sp. z o.o.
Vantage Trading sp. z o.o.
Midas Pharma Polska sp. z o.o.
Alfa Sagittarius Jerzy Kowynia sp. k.
Cardinal Pharma S.A.
Actifarm sp. z o.o.
Pube Global sp. z o.o.
NTC Andar sp. z o.o.
Opta Healthcare sp. z o.o.

Change history

DateEvent
2025-11-12Business suspended
2020-01-09Entered in the register

FAQ

Last updated: 2026-04-17